|
Volumn 3, Issue 10, 2007, Pages 544-545
|
Do high levels of IgA rheumatoid factor indicate a poor response to treatment with TNF inhibitors in patients with RA?: Commentary
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADALIMUMAB;
AUTOANTIBODY;
CYCLIC CITRULLINATED PEPTIDE ANTIBODY;
DISEASE MODIFYING ANTIRHEUMATIC DRUG;
ETANERCEPT;
IMMUNOGLOBULIN A;
IMMUNOGLOBULIN G;
IMMUNOGLOBULIN M;
INFLIXIMAB;
METHOTREXATE;
RHEUMATOID FACTOR;
RITUXIMAB;
TUMOR NECROSIS FACTOR ALPHA INHIBITOR;
ANTIBODY BLOOD LEVEL;
ANTIBODY PRODUCTION;
ANTIBODY RESPONSE;
B LYMPHOCYTE;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
DISEASE ACTIVITY;
DRUG RESPONSE;
HUMAN;
IMMUNOGLOBULIN BLOOD LEVEL;
IMMUNOGLOBULIN PRODUCTION;
INFLAMMATION;
JOINT DESTRUCTION;
MONOTHERAPY;
PRIORITY JOURNAL;
QUESTIONNAIRE;
RHEUMATOID ARTHRITIS;
SCORING SYSTEM;
SHORT SURVEY;
VASCULITIS;
|
EID: 34848897201
PISSN: 17458382
EISSN: 17458390
Source Type: Journal
DOI: 10.1038/ncprheum0596 Document Type: Short Survey |
Times cited : (2)
|
References (5)
|